5-Amino-1MQ

5-Amino-1MQ is the odd one out in this catalogue: it is not a peptide, it is a small molecule, and it is taken orally rather than injected. If needles are what has been putting you off, this and the oral peptides are where to start.

It works by blocking an enzyme called NNMT. That enzyme does two unhelpful things at once inside fat cells: it consumes NAD+, the coenzyme cells run their energy metabolism on, and it produces a metabolite that appears to slow fat cell metabolism further. NNMT is overexpressed in fat tissue to begin with and rises further as fat mass increases, which makes it something of a self-reinforcing problem.

Blocking it does two things in one move: fat cell metabolism speeds back up, and NAD+ levels inside those cells rise because nothing is burning through it. That second effect is why people report energy alongside the fat loss.

The evidence is animal and cell work. It is genuinely promising, the mechanism is well described, and the human trials do not exist yet. That is the honest position.

NNMT stands for nicotinamide N-methyltransferase, and it sits at an awkward junction in cellular metabolism. Its job is to methylate nicotinamide, and in doing so it consumes both a methyl group and, indirectly, the pool of nicotinamide that would otherwise be recycled back into NAD+.

In fat tissue NNMT is expressed at high levels, and higher still as fat mass increases. The consequence is fat cells with less NAD+ available and a slower metabolic rate: exactly the wrong direction if the aim is to reduce fat mass.

5-Amino-1MQ blocks the enzyme. Nicotinamide is no longer being consumed, so NAD+ rises inside the cell, and the metabolite that was slowing things down is no longer being produced. Fat cell metabolism increases as a result.

The most notable thing in the animal work is that the fat loss happened without any change in food intake. This is not an appetite compound and it does not make you eat less. It changes what the cells do with what you have already eaten.

5-Amino-1MQ is well tolerated in the animal work at doses far above the human range, and user reports are consistent with that. The most common complaint is mild nausea when it is taken on an empty stomach, which taking it with food resolves.

The significant caveat is the evidence base. There are no human clinical trials. Everything here comes from animal and cell studies plus user reports, and the long-term human safety picture is genuinely unknown. That is a bigger unknown than for most compounds in this catalogue.

NNMT is involved in methylation, and inhibiting it has downstream effects on methyl group availability that are not fully mapped in humans. Some people run a B-vitamin complex alongside for that reason; the reasoning is sensible but it is reasoning rather than evidence.

Do not inject this. It is supplied as an oral compound and the vial is not formulated for injection.

Do not use during pregnancy or breastfeeding, and speak to a doctor first if you take prescription medication or have an existing condition.